How much funding has Dilon Technologies raised?

Dilon Technologies has disclosed $45.7M raised across 6 rounds.

Where is Dilon Technologies headquartered?

Dilon Technologies is headquartered in Newport News, US.

Dilon Technologies

Newport News, US · Delaware corporation

Find your way into Dilon Technologies

Paths you didn't know you had: your email and LinkedIn already hold routes to the Dilon Technologies team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Dilon Technologies is a medical device manufacturer that develops surgical instruments and diagnostic tools for healthcare practitioners, including gamma probes for lymphatic mapping, margin assessment devices for breast cancer surgery, and video laryngoscopes.

Biotech FemTech Hardware Medical Devices

Founders & leadership

Tim Jette Chief Financial OfficerTim Jette holds an inactive CPA credential and has held finance leadership roles in strategic planning, debt financing, manufacturing, business development, and public accounting. He served on the Massachusetts Medical Device Industry Council board.

George Makhoul Chief Executive OfficerGeorge Makhoul has more than 20 years of experience in healthcare, including leadership roles in medical devices, biologics, and pharmaceutical companies with revenue ranging from under $10 million to over $1 billion, with expertise spanning product development, FDA regulatory pathways, sales channel management, and acute care market penetration.

Robert G. MoussaExecutive

Vijay Singh VP, International Sales & Operations2002–2024Executive Officer of Dilon Technologies, which develops and manufactures medical devices including surgical instruments and diagnostic tools such as gamma probes for lymphatic mapping and margin assessment devices for breast cancer surgery.

Pjerin Luli Chief Commercial OfficerExecutive Officer at Dilon Technologies, a manufacturer of surgical instruments and diagnostic tools including gamma probes for lymphatic mapping and margin assessment devices for breast cancer surgery.

Michael W. TillerCFO2008–2023

Benjamin Welch Vice President of Science and Technology2015–2019Benjamin Welch holds a PhD in Physics from the University of Maryland and previously served as Vice President of Science and Technology at Dilon Diagnostics, where he led development of the Dilon 6800 gamma camera for breast cancer detection and oversaw clinical studies, FDA approval, and product launch. He has conducted research in X-ray lasers and fusion reactor diagnostics at institutions including MIT, Lawrence Livermore National Laboratory, and the Naval Research Laboratory.

Board

Michael N. TaglichBoard director

Robert TaglichBoard director

Mark H. RavichBoard director

Rachel F. BremBoard director

Francis BissaillonBoard director

Reported raises · per SEC filings

Form D private placements

$45.7M disclosed across 6 rounds · 2017–2025

▶$8.1MraisedMar 2026 · 184 investors · Biotechnology

Rule 506(b)